Edible Garden (EDBL) Q1 2026 earnings review
Top-Line Acceleration Masks a Severe Margin Collapse
Edible Garden delivered an accelerating 22.9% revenue increase in Q1, but the quality of this growth is deeply concerning. The top-line beat was fueled by a 46% surge in cut herbs, which management admitted was fulfilled using expensive third-party growers. Consequently, Cost of Goods Sold soared 57%, wiping out any operating leverage and driving gross margins down to an abysmal -31.4%. Operating losses doubled year-over-year to $6.68 million, exacerbated by a massive non-cash depreciation charge tied to the company's aggressive pivot toward Ready-to-Drink (RTD) manufacturing. With less than $2 million in cash remaining, the company is attempting a highly capital-intensive transformation while its core business bleeds money.
🐂 Bull Case
The diversification strategy is showing life. Condiments (+51%) and Vitamins/Supplements (+27%) posted strong YoY growth, validating the 'Farm-to-Formula' strategy into higher-value categories.
The company continues to expand its physical reach, now operating in over 6,000 retail locations and securing new placements with heavyweights like Target and Safeway.
🐻 Bear Case
The core growth driver this quarter (cut herbs) is structurally unprofitable when scaled through third-party sourcing. The company is essentially buying top-line revenue at the expense of its balance sheet.
With only $1.95 million in cash against $7.7 million in current liabilities and a $6.7 million operating burn this quarter, an aggressive, dilutive capital raise appears imminent to fund the RTD buildout.
⚖️ Verdict: 🔴
Bearish. The narrative of strategic evolution is overshadowed by brutal unit economics. Growing revenue by selling products at a steep gross loss, combined with a precarious cash position, makes the current trajectory unsustainable.
Key Themes
Profitless Top-Line Growth Contradicts Positive Narrative
Management highlighted the 22.9% revenue growth as proof that investments are 'translating into measurable growth.' However, the data reveals a different story: Cost of Goods Sold surged 57.4%. Gross margin collapsed from -2.6% in 25Q1 to -31.4% in 26Q1. The 46% growth in cut herbs was fueled by expensive third-party sourcing, meaning the company lost significantly more money on every new unit sold.
Severe Liquidity Crunch
The balance sheet is signaling intense stress. Edible Garden ended Q1 with just $1.95 million in cash. Meanwhile, current liabilities stand at $7.7 million, including $5.09 million in accounts payable and $2.2 million in short-term debt. Given the $6.68 million operating loss in a single quarter, the company lacks the internal capital required to execute its ambitious RTD plant buildout.
Accelerated Depreciation and Capex Burden
Operating expenses spiked 77.5% YoY to $10.0 million, driven primarily by a $2.5 million increase in depreciation. This non-cash charge is the result of writing down legacy assets to pivot the Midwest facility toward RTD manufacturing. While non-cash today, it highlights the immense capital burden and execution risk associated with retrofitting an agricultural facility into a beverage plant.
Shelf-Stable Portfolio Gaining Traction
The non-perishable segments are executing well. Condiments (Pulp, Pickle Party) surged 51% YoY, and Vitamins and Supplements grew 27%. If Edible Garden can successfully pivot its revenue mix away from low-margin fresh produce, these shelf-stable lines offer a structurally superior long-term unit economic profile.
Retail Network Expansion
The company’s most valuable asset is its distribution moat. Edible Garden expanded its reach to over 6,000 retail locations, successfully onboarding or expanding with Target, Safeway, The Fresh Market, and Hannaford. This existing shelf space is the critical launchpad for the upcoming RTD beverage lines.
Tetra Pak Integration and Aseptic Technology
In a major technological shift, Edible Garden is integrating Tetra Pak processing and aseptic packaging solutions at its Midwest facility. This specific manufacturing capability is designed to produce clean-label, shelf-stable functional beverages, solving a critical capacity bottleneck in the domestic co-manufacturing market.
Macro Tailwind: Functional Nutrition
Management's pivot is deeply tied to a massive macro trend: the global Ready-to-Drink (RTD) market is projected to grow from $842.5 billion in 2025 to $1.26 trillion by 2033. Retailers are actively demanding scalable, domestic supply chains for clean-label, wellness-focused offerings, providing a strong demand environment if the company can survive to meet it.
Other KPIs
Deteriorating sharply from a -$2.93 million loss in the prior year. The collapse was driven entirely by negative gross margins from third-party herb sourcing and a $2.7 million depreciation expense. The core business is currently not generating cash.
A one-time, non-operating lifeline. This valuation allowance release, related to the sale of New Jersey state tax benefits, artificially shielded the bottom line. Without this paper benefit, the reported Net Loss of $3.67 million would have mirrored the severe $7.0 million pre-tax loss.
Guidance
Accelerating. The company is actively integrating Tetra Pak processing at the Prairie Hills facility. Management provided no explicit quantitative revenue guidance for 2026, but noted that they are focused on establishing scalable domestic production to meet unmet retailer demand.
Key Questions
Financing the RTD Pivot
With only $1.95 million in cash, an operating cash burn, and $7.7 million in current liabilities, how exactly does management plan to finance the completion of the Tetra Pak RTD facility without highly dilutive equity raises?
Path to Profitability for Cut Herbs
Cut herbs grew 46% but required third-party sourcing that destroyed gross margins. Is there a concrete timeline to bring this production in-house, or will this segment remain a perpetual loss-leader to hold retail shelf space?
RTD Commercialization Timeline
Given the accelerated depreciation charges taken this quarter for the facility retrofit, when exactly should investors expect the first commercial revenues from the new RTD Tetra Pak lines to hit the income statement?